Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
To determine if Itacitinib in combination with corticosteroids is safe and tolerable in
patients with Grade IIB-IVD acute graft-versus-host disease (GVHD).